This is a type of tumor that starts in the cells that make estrogen, usually in the ovary. It's often benign (not cancer), but it can sometimes become cancerous. It can cause too much estrogen, which can lead to other problems.
Every report comes from a Lived member, sent anonymously.
Have you had Salpingo-oophorectomy for Granulosa Cell Tumor?
A granulosa cell tumor is a rare type of ovarian cancer that starts in granulosa cells, the cells that normally surround a developing egg and make hormones. Unlike the more common ovarian cancers, which start in the ovary's surface lining, these tumors usually grow slowly and are most often found while still confined to one ovary. Because granulosa cells make hormones, many of these tumors produce estrogen. In adults this can cause irregular periods, bleeding between periods or bleeding after menopause, and over time it can thicken the lining of the uterus and raise the risk of uterine (endometrial) cancer. A large tumor can also cause abdominal pain, bloating or a feeling of fullness. There are two main types. The adult type accounts for most cases and is usually diagnosed around midlife, although it can occur at any age. The juvenile type mostly affects children, teenagers and young adults, and in young girls the extra estrogen can cause early breast development and vaginal bleeding before the usual age of puberty. Very rarely, granulosa cell tumors develop in the testicle instead of the ovary.
The cause of most granulosa cell tumors is not known. Nearly all adult-type tumors carry a change in a gene called FOXL2, which helps control normal granulosa cell development. This change arises within the tumor itself during a person's life; it is not inherited and is not passed to children. The juvenile type has different genetic changes. Occasionally, granulosa cell tumors occur alongside another condition, such as Peutz-Jeghers syndrome (an inherited condition that causes growths in the digestive tract) or Ollier disease (which causes benign growths in cartilage), so a care team may suggest genetic counseling for a child or young adult. There are no known lifestyle causes, and nothing a person did is known to bring one on.
Diagnosis usually starts with a pelvic exam and an ultrasound after someone notices abnormal bleeding, pain or a swollen abdomen, or when a mass is found during a scan for another reason. These tumors often look like a large mass with both solid and fluid-filled areas. CT or MRI scans can show the tumor's size and whether it has spread. Blood tests can add useful clues. Inhibin and anti-Müllerian hormone (AMH) are hormones that granulosa cells make, and they are often raised when one of these tumors is present. They are not proof on their own, because other ovarian tumors can also raise them, but if they are high before surgery they become a valuable way to watch for the tumor returning later. The diagnosis is confirmed when a pathologist examines the tumor after it is removed, sometimes with a test for the FOXL2 change in unclear cases. During surgery, the surgeon also checks whether the tumor has spread, which determines its stage. Because years of estrogen exposure can affect the uterus, a sample of the uterine lining (an endometrial biopsy) is usually taken when the uterus is kept, to look for thickening or cancer.
Surgery is the main treatment and is often the only treatment needed. For people who have finished having children or are past menopause, it usually means removing the uterus, both ovaries and fallopian tubes, and checking nearby tissue for spread. For younger people with an early-stage tumor who want to keep the option of pregnancy, removing only the affected ovary and tube is a well-established choice; in children with the juvenile type, sparing fertility is the usual approach. The trade-off is that the remaining ovary needs continued monitoring. Most early-stage tumors need no further treatment after surgery. For a tumor that ruptured or had broken through the ovary's surface, specialists sometimes discuss chemotherapy, but studies of this group have not shown that it lowers the chance of recurrence, so the decision depends on the tumor type and the person's situation. Chemotherapy is used more clearly for advanced disease, often combining a platinum drug such as cisplatin or carboplatin with other medicines. When the tumor comes back, surgery to remove it is usually tried first if it is possible. Because many of these tumors depend on hormones, hormone-blocking medicines are another option. Aromatase inhibitors such as letrozole and anastrozole, which lower the body's estrogen, are the most studied; they more often hold the tumor steady than shrink it. Radiation and clinical trials of newer drugs are other possibilities. Since this cancer is rare, much of the treatment evidence comes from small studies, which is a good reason to be treated by, or consult, a gynecologic oncologist (a surgeon who specializes in cancers of the female reproductive system).
The outlook for a granulosa cell tumor found early is very good. Most are diagnosed at stage I, and the large majority of these people live for many years after surgery. The outlook is less favorable when the cancer has spread through the abdomen at diagnosis. The juvenile type confined to one ovary is usually cured by surgery, while advanced juvenile tumors tend to come back sooner than the adult type. What sets the adult type apart is its habit of returning late. Roughly one in five adult-type tumors recurs after surgery, typically 5 to 10 years later and sometimes after 20 years or more. Recurrent disease can often be removed again or controlled for long periods, but it is a reason follow-up continues for many years, often for life. Visits usually include an exam, blood tests for inhibin or AMH if they were raised before surgery, and imaging when needed. Surgery that removes both ovaries brings on menopause right away for someone who has not yet reached it, with hot flashes, sleep changes and long-term effects on bone and heart health. Because these tumors are hormone-sensitive, most guidelines advise against standard menopausal hormone therapy afterward, although there is no direct evidence showing whether it is harmful. This is a decision to work through with the oncology team, along with other ways to manage symptoms and protect bone health. People who kept an ovary often go on to have pregnancies, and the care team can advise on timing and monitoring.
See a clinician about bleeding after menopause, new bleeding between periods or periods that stop without explanation, or a swollen abdomen or pelvic pain that persists. In a child, breast development or vaginal bleeding well before the usual age of puberty needs evaluation. After treatment, contact your care team if a tumor marker rises, or if unexplained bleeding, abdominal swelling or pelvic pain returns, even many years later. Rarely, these tumors rupture and bleed inside the abdomen. Sudden, severe abdominal pain, especially with lightheadedness or fainting, needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Granulosa Cell Tumor is like, what's helped you, or ask the community a question.